Synergistic effects of arsenic trioxide and radiation in osteosarcoma cells through the induction of both autophagy and apoptosis

Hui Wen Chiu, Wei Lin, Sheng Yow Ho, Ying Jan Wang

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Osteosarcoma is the most common primary malignant bone tumor, occurring mainly in children and adolescents, and survival largely depends on their response to chemotherapy. However, the risk of relapse and adverse outcomes is still high. We investigated the synergistic anti-cancer effects of ionizing radiation combined with arsenic trioxide (ATO) and the mechanisms underlying apoptosis or autophagy induced by combined radiation and ATO treatment in human osteosarcoma cells. We found that exposure to radiation increased the population of HOS cells in the G2/M phase within 12 h in a time-dependent manner. Radiation combined with ATO induced a significantly prolonged G2/M arrest, consequently enhancing cell death. Furthermore, combined treatment resulted in enhanced ROS generation compared to treatment with ATO or radiation alone. The enhanced cytotoxic effect of combined treatment occurred from the increased induction of autophagy and apoptosis through inhibition of the PI3K/Akt signaling pathway in HOS cells. The combined treatment of HOS cells pretreated with Z-VAD, 3-MA or PEG-catalase resulted in a significant reduction of cytotoxicity. In addition, G2/M arrest and ROS generation could be involved in the underlying mechanisms. The data suggest that a combination of radiation and ATO could be a new potential therapeutic strategy for the treatment of osteosarcoma.

Original languageEnglish
Pages (from-to)547-560
Number of pages14
JournalRadiation Research
Volume175
Issue number5
DOIs
Publication statusPublished - May 2011
Externally publishedYes

Fingerprint

Autophagy
apoptosis
Osteosarcoma
arsenic
induction
Radiation
Apoptosis
radiation
cells
Therapeutics
catalase
chemotherapy
G2 Phase
death
ionizing radiation
bones
Ionizing Radiation
arsenic trioxide
Phosphatidylinositol 3-Kinases
Cell Division

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Biophysics
  • Radiation

Cite this

Synergistic effects of arsenic trioxide and radiation in osteosarcoma cells through the induction of both autophagy and apoptosis. / Chiu, Hui Wen; Lin, Wei; Ho, Sheng Yow; Wang, Ying Jan.

In: Radiation Research, Vol. 175, No. 5, 05.2011, p. 547-560.

Research output: Contribution to journalArticle

@article{5bd0a16b90f7443fb52d29fef5837f75,
title = "Synergistic effects of arsenic trioxide and radiation in osteosarcoma cells through the induction of both autophagy and apoptosis",
abstract = "Osteosarcoma is the most common primary malignant bone tumor, occurring mainly in children and adolescents, and survival largely depends on their response to chemotherapy. However, the risk of relapse and adverse outcomes is still high. We investigated the synergistic anti-cancer effects of ionizing radiation combined with arsenic trioxide (ATO) and the mechanisms underlying apoptosis or autophagy induced by combined radiation and ATO treatment in human osteosarcoma cells. We found that exposure to radiation increased the population of HOS cells in the G2/M phase within 12 h in a time-dependent manner. Radiation combined with ATO induced a significantly prolonged G2/M arrest, consequently enhancing cell death. Furthermore, combined treatment resulted in enhanced ROS generation compared to treatment with ATO or radiation alone. The enhanced cytotoxic effect of combined treatment occurred from the increased induction of autophagy and apoptosis through inhibition of the PI3K/Akt signaling pathway in HOS cells. The combined treatment of HOS cells pretreated with Z-VAD, 3-MA or PEG-catalase resulted in a significant reduction of cytotoxicity. In addition, G2/M arrest and ROS generation could be involved in the underlying mechanisms. The data suggest that a combination of radiation and ATO could be a new potential therapeutic strategy for the treatment of osteosarcoma.",
author = "Chiu, {Hui Wen} and Wei Lin and Ho, {Sheng Yow} and Wang, {Ying Jan}",
year = "2011",
month = "5",
doi = "10.1667/RR2380.1",
language = "English",
volume = "175",
pages = "547--560",
journal = "Radiation Research",
issn = "0033-7587",
publisher = "Radiation Research Society",
number = "5",

}

TY - JOUR

T1 - Synergistic effects of arsenic trioxide and radiation in osteosarcoma cells through the induction of both autophagy and apoptosis

AU - Chiu, Hui Wen

AU - Lin, Wei

AU - Ho, Sheng Yow

AU - Wang, Ying Jan

PY - 2011/5

Y1 - 2011/5

N2 - Osteosarcoma is the most common primary malignant bone tumor, occurring mainly in children and adolescents, and survival largely depends on their response to chemotherapy. However, the risk of relapse and adverse outcomes is still high. We investigated the synergistic anti-cancer effects of ionizing radiation combined with arsenic trioxide (ATO) and the mechanisms underlying apoptosis or autophagy induced by combined radiation and ATO treatment in human osteosarcoma cells. We found that exposure to radiation increased the population of HOS cells in the G2/M phase within 12 h in a time-dependent manner. Radiation combined with ATO induced a significantly prolonged G2/M arrest, consequently enhancing cell death. Furthermore, combined treatment resulted in enhanced ROS generation compared to treatment with ATO or radiation alone. The enhanced cytotoxic effect of combined treatment occurred from the increased induction of autophagy and apoptosis through inhibition of the PI3K/Akt signaling pathway in HOS cells. The combined treatment of HOS cells pretreated with Z-VAD, 3-MA or PEG-catalase resulted in a significant reduction of cytotoxicity. In addition, G2/M arrest and ROS generation could be involved in the underlying mechanisms. The data suggest that a combination of radiation and ATO could be a new potential therapeutic strategy for the treatment of osteosarcoma.

AB - Osteosarcoma is the most common primary malignant bone tumor, occurring mainly in children and adolescents, and survival largely depends on their response to chemotherapy. However, the risk of relapse and adverse outcomes is still high. We investigated the synergistic anti-cancer effects of ionizing radiation combined with arsenic trioxide (ATO) and the mechanisms underlying apoptosis or autophagy induced by combined radiation and ATO treatment in human osteosarcoma cells. We found that exposure to radiation increased the population of HOS cells in the G2/M phase within 12 h in a time-dependent manner. Radiation combined with ATO induced a significantly prolonged G2/M arrest, consequently enhancing cell death. Furthermore, combined treatment resulted in enhanced ROS generation compared to treatment with ATO or radiation alone. The enhanced cytotoxic effect of combined treatment occurred from the increased induction of autophagy and apoptosis through inhibition of the PI3K/Akt signaling pathway in HOS cells. The combined treatment of HOS cells pretreated with Z-VAD, 3-MA or PEG-catalase resulted in a significant reduction of cytotoxicity. In addition, G2/M arrest and ROS generation could be involved in the underlying mechanisms. The data suggest that a combination of radiation and ATO could be a new potential therapeutic strategy for the treatment of osteosarcoma.

UR - http://www.scopus.com/inward/record.url?scp=79955416811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955416811&partnerID=8YFLogxK

U2 - 10.1667/RR2380.1

DO - 10.1667/RR2380.1

M3 - Article

VL - 175

SP - 547

EP - 560

JO - Radiation Research

JF - Radiation Research

SN - 0033-7587

IS - 5

ER -